IMMU-TON SUPREME
Natural health product licensed in Canada
- Licence holder
- Placements Limoges Inc. / Limoges Holdings Inc.
- NPN or DIN-HM
- 80089070
- Status
- Active licence
- Licence date
- 7 November 2018
- Revision date
- 17 March 2021
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Allium sativum Source : Bulbe Extraction ratio : 1:1 Dry plant equivalent : 25.5 mg | 25.5 mg | Not calculated |
| Echinacea angustifolia Source : Racine Extraction ratio : 1:1 Dry plant equivalent : 126.5 mg | 126.5 mg | Not calculated |
| Echinacea purpurea Source : Racine Extraction ratio : 1:1 Dry plant equivalent : 63.5 mg | 63.5 mg | Not calculated |
Non-medicinal ingredients
Eau (Aqua), Alcool
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 15 years | minimum: 1 mL ; maximum: 1.5 mL | minimum: 3 days ; maximum: 4 days |
Uses authorised in Canada
Utilisée traditionnellement en phytothérapie/herboristerie pour aider à soulager les symptômes d'infections des voies respiratoires supérieures. Utilisée traditionnellement en phytothérapie/herboristerie pour aider à soulager les maux de gorge.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Une hypersensibilité (p.ex., une allergie) peut se manifester. Si tel est le cas, cesser l'utilisation.
- Précautions et mises en garde
Si les symptômes persistent ou s'aggravent, consulter un praticien de soins de santé. Si vous souffrez d'une maladie systèmique progressive telle que la tuberculose, la collagénose, la sclérose en plaques, le sida et/ou une infection au VIH, consulter un practicien de soins de santé avant d'en faire l'usage. Si vous souffrez d'une maladie auto-immune, consulter un practicien de soins de santé avant d'en faire l'usage. Si vous prenez des immunosuppresseurs, consulter un practicien de soins de santé avant d'en faire l'usage. Consultez un practicien de soins de santé si vous êtes enceinte ou si vous allaitez. Garder hors de portée des enfants. En cas de surdosage ou d'ingestion accidentelle, appeler un Centre Antipoison immédiatement. Si vous souffrez d'ulcères d'estomac ou d'inflammation, consulter un practicien de soins de santé avant d'en faire l'usage.
Source
Official Health Canada record, licence 80089070
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Allium sativum
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Echinacea angustifolia
Read the warning, when it applies and the studies cited
ECHINACEA- ECHINACEA ANGUSTIFOLIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (Gardner and McGuffin 2013; Brinker 2010).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Echinacea purpurea
Read the warning, when it applies and the studies cited
ECHINACEA - ECHINACEA PURPUREA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Preparations containing herb top.
Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.